Literature DB >> 18400316

Biochemical and biophysical properties of a highly active recombinant arginase from Leishmania (Leishmania) amazonensis and subcellular localization of native enzyme.

Edson Roberto da Silva1, Maria Fernanda Laranjeira da Silva, Hannes Fischer, Renato A Mortara, Mario Gustavo Mayer, Karine Framesqui, Ariel Mariano Silber, Lucile Maria Floeter-Winter.   

Abstract

Arginase (L-arginine amidinohydrolase, E.C. 3.5.3.1) is a metalloenzyme that catalyses the hydrolysis of L-arginine to L-ornithine and urea. In Leishmania spp., the biological role of the enzyme may be involved in modulating NO production upon macrophage infection. Previously, we cloned and characterized the arginase gene from Leishmania (Leishmania) amazonensis. In the present work, we successfully expressed the recombinant enzyme in E. coli and performed biochemical and biophysical characterization of both the native and recombinant enzymes. We obtained K(M) and V(max) values of 23.9(+/-0.96) mM and 192.3 micromol/min mg protein (+/-14.3), respectively, for the native enzyme. For the recombinant counterpart, K(M) was 21.5(+/-0.90) mM and V(max) was 144.9(+/-8.9) micromol/min mg. Antibody against the recombinant protein confirmed a glycosomal cellular localization of the enzyme in promastigotes. Data from light scattering and small angle X-ray scattering showed that a trimeric state is the active form of the protein. We determined empirically that a manganese wash at room temperature is the best condition to purify active enzyme. The interaction of the recombinant protein with the immobilized nickel also allowed us to confirm the structural disposition of histidine at positions 3 and 324. The determined structural parameters provide substantial data to facilitate the search for selective inhibitors of parasitic sources of arginase, which could subsequently point to a candidate for leishmaniasis therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18400316     DOI: 10.1016/j.molbiopara.2008.02.011

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  12 in total

1.  Inhibition profile of Leishmania mexicana arginase reveals differences with human arginase I.

Authors:  Eric Riley; Sigrid C Roberts; Buddy Ullman
Journal:  Int J Parasitol       Date:  2011-01-11       Impact factor: 3.981

2.  In vitro antileishmanial activity of fisetin flavonoid via inhibition of glutathione biosynthesis and arginase activity in Leishmania infantum.

Authors:  Keivan Adinehbeigi; Mohammad Hossein Razi Jalali; Ali Shahriari; Somayeh Bahrami
Journal:  Pathog Glob Health       Date:  2017-04-07       Impact factor: 2.894

3.  Crystal structure of arginase from Leishmania mexicana and implications for the inhibition of polyamine biosynthesis in parasitic infections.

Authors:  Edward L D'Antonio; Buddy Ullman; Sigrid C Roberts; Upasna Gaur Dixit; Mary E Wilson; Yang Hai; David W Christianson
Journal:  Arch Biochem Biophys       Date:  2013-04-09       Impact factor: 4.013

4.  Leishmania major lacking arginase (ARG) are auxotrophic for polyamines but retain infectivity to susceptible BALB/c mice.

Authors:  Rosa M Reguera; Rafael Balaña-Fouce; Melissa Showalter; Suzanne Hickerson; Stephen M Beverley
Journal:  Mol Biochem Parasitol       Date:  2009-01-20       Impact factor: 1.759

5.  Leishmania amazonensis arginase compartmentalization in the glycosome is important for parasite infectivity.

Authors:  Maria Fernanda Laranjeira da Silva; Ricardo Andrade Zampieri; Sandra M Muxel; Stephen M Beverley; Lucile M Floeter-Winter
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

6.  Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites.

Authors:  Alireza Badirzadeh; Tahereh Taheri; Yasaman Taslimi; Zahra Abdossamadi; Maryam Heidari-Kharaji; Elham Gholami; Baharehsadat Sedaghat; Maryam Niyyati; Sima Rafati
Journal:  PLoS Negl Trop Dis       Date:  2017-07-14

7.  L-arginine availability and arginase activity: Characterization of amino acid permease 3 in Leishmania amazonensis.

Authors:  Juliana Ide Aoki; Sandra Marcia Muxel; Ricardo Andrade Zampieri; Stephanie Maia Acuña; Juliane Cristina Ribeiro Fernandes; Rubia Heloisa Vanderlinde; Maria Carmen Oliveira de Pinho Sales; Lucile Maria Floeter-Winter
Journal:  PLoS Negl Trop Dis       Date:  2017-10-26

Review 8.  Arginine and Polyamines Fate in Leishmania Infection.

Authors:  Sandra M Muxel; Juliana I Aoki; Juliane C R Fernandes; Maria F Laranjeira-Silva; Ricardo A Zampieri; Stephanie M Acuña; Karl E Müller; Rubia H Vanderlinde; Lucile M Floeter-Winter
Journal:  Front Microbiol       Date:  2018-01-15       Impact factor: 5.640

Review 9.  The Uptake and Metabolism of Amino Acids, and Their Unique Role in the Biology of Pathogenic Trypanosomatids.

Authors:  Letícia Marchese; Janaina de Freitas Nascimento; Flávia Silva Damasceno; Frédéric Bringaud; Paul A M Michels; Ariel Mariano Silber
Journal:  Pathogens       Date:  2018-04-01

10.  Untargeted metabolomics reveals a lack of synergy between nifurtimox and eflornithine against Trypanosoma brucei.

Authors:  Isabel M Vincent; Darren J Creek; Karl Burgess; Debra J Woods; Richard J S Burchmore; Michael P Barrett
Journal:  PLoS Negl Trop Dis       Date:  2012-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.